PITTSBURGH — A coalition of consumer advocacy groups is urging the federal government to block a hostile takeover of generic drugmaker Mylan by Israel’s Teva Pharmaceutical Industries, saying the combination of the two drug giants could lead to higher prices for generic medications. In a Tuesday letter to the Federal Trade Commission from eight groups, including Consumers Union, the Consumer Federation of America and U.S.